# Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial

> **NCT07019610** · NA · NOT_YET_RECRUITING · sponsor: **The University of Queensland** · enrollment: 60 (estimated)

## Conditions studied

- Vascular Access Complication
- Device Related Infection
- Device Related Sepsis
- Catheter Infection
- Catheter Complications
- Catheter-Related Infections
- Catheter Related Complications
- Hemodialysis Catheter Infection
- Hemodialysis Catheter-associated Infection
- Hemodialysis Complication

## Interventions

- **DEVICE:** ClearGuard HD
- **DEVICE:** B Braun Combi-stopper

## Key facts

- **NCT ID:** NCT07019610
- **Lead sponsor:** The University of Queensland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-12
- **Final completion:** 2028-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07019610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07019610, "Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT07019610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*